Exact Mass: 591.3407

Exact Mass Matches: 591.3407

Found 15 metabolites which its exact mass value is equals to given mass value 591.3407, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

veratrine

1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl 2-methylbut-2-enoate

C32H49NO9 (591.3407)


   

veratrine

veratrine

C32H49NO9 (591.3407)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids D049990 - Membrane Transport Modulators > D062687 - Sodium Channel Agonists

   

15-Angeloylgermine

15-Angeloylgermine

C32H49NO9 (591.3407)


   

Angeloylzygadenine beta-N-oxide

Angeloylzygadenine beta-N-oxide

C32H49NO9 (591.3407)


   

cevadine

veratrine

C32H49NO9 (591.3407)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids D049990 - Membrane Transport Modulators > D062687 - Sodium Channel Agonists CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2333

   

Cevadin

veratrine

C32H49NO9 (591.3407)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids D049990 - Membrane Transport Modulators > D062687 - Sodium Channel Agonists

   

6-Hexadecanoylamido-4-methylumbelliferyl-beta-D-galactopyranoside

6-Hexadecanoylamido-4-methylumbelliferyl-beta-D-galactopyranoside

C32H49NO9 (591.3407)


   

Everolimus Impurity 3

Everolimus Impurity 3

C32H49NO9 (591.3407)


   
   
   

ST 24:3;O4;HexNAc

ST 24:3;O4;HexNAc

C32H49NO9 (591.3407)


   

10,12,14,16,22,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-13-yl 2-methylbut-2-enoate

10,12,14,16,22,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-13-yl 2-methylbut-2-enoate

C32H49NO9 (591.3407)


   

(1s,2s,4r,6s,9s,10s,11r,12r,13s,14s,15s,18s,19s,22s,23s,25r)-10,12,13,14,23-pentahydroxy-6,10,19-trimethyl-22-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-4-ium-4-olate

(1s,2s,4r,6s,9s,10s,11r,12r,13s,14s,15s,18s,19s,22s,23s,25r)-10,12,13,14,23-pentahydroxy-6,10,19-trimethyl-22-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-4-ium-4-olate

C32H49NO9 (591.3407)


   

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,16r,18s,19s,22s,23s,25r)-10,12,14,16,22,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-13-yl (2z)-2-methylbut-2-enoate

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,16r,18s,19s,22s,23s,25r)-10,12,14,16,22,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-13-yl (2z)-2-methylbut-2-enoate

C32H49NO9 (591.3407)


   

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,18s,19s,22s,23s,25r)-10,12,13,14,23-pentahydroxy-6,10,19-trimethyl-22-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-4-ium-4-olate

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,18s,19s,22s,23s,25r)-10,12,13,14,23-pentahydroxy-6,10,19-trimethyl-22-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-4-ium-4-olate

C32H49NO9 (591.3407)